Adaptive 4D Volume Perfusion CT of Lung Cancer: Effects of Computerized Motion Correction and the Range of Volume Coverage on Measurement Reproducibility

被引:16
作者
Lee, Sang Min [1 ]
Lee, Hyun-Ju [1 ]
Kim, Jung Im [1 ]
Kang, Mi-Jin [2 ]
Goo, Jin Mo [1 ]
Park, Chang Min [1 ]
Im, Jung-Gi [1 ]
机构
[1] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea
[2] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Radiol, Seoul, South Korea
关键词
lung cancer; motion correction; perfusion CT; reproducibility; tumor coverage; AGREEMENT; NODULES; TUMORS; VPCT; TIME; FLOW;
D O I
10.2214/AJR.12.9458
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The purpose of this study was to determine whether measurement reproducibility can be improved using computerized motion correction and whole-tumor coverage in adaptive 4D perfusion CT of lung cancer. SUBJECTS AND METHODS. Perfusion CT covering the entire z-axis of a mass was performed of 40 patients with lung cancer. Each perfusion CT study was performed in 93.5 seconds and included 17 repeated dynamic CT scans obtained using the Adaptive 4D Spiral mode. Tumor blood flow (BF), blood volume (BV), and permeability were measured in four different manners: in the entire tumor (whole-tumor coverage) without the use of motion correction; in the entire tumor with motion correction; in a small volume of interest (VOI) of tumor without motion correction; and in a small VOI with motion correction. Intra-and interobserver reproducibility were assessed through Bland-Altman analyses. RESULTS. The 95% limits of intraobserver reproducibility for BF, BV, and permeability were as follows: -52.1% to 48.0%, -22.4% to 27.8%, and -33.2% to 38.5%, respectively, in the whole tumor without motion correction; -53.3% to 45.6%, -17.7% to 20.6%, and -31.5% to 37.0% in the whole tumor with motion correction; -107.8% to 97.4%, -98.3% to 93.7%, and -132.3% to 100.7% in a small VOI of tumor without motion correction; and -74.9% to 98.6%, -74.5% to 88.1%, and -109.8% to 114.1% in a small VOI with motion correction. The 95% limits of interobserver reproducibility for BF, BV, and permeability were as follows: -57.0% to 62.5%, -36.8% to 52.6%, and -47.7% to 66.0%, respectively, in the whole tumor without motion correction; -55.7% to 55.8%, -25.8% to 42.0%, and -35.3% to 46.7% in the whole tumor with motion correction; -146.6% to 165.1%, -117.1% to 137.7%, and -143.2% to 149.8% in a small VOI of tumor without motion correction; and -106.2% to 133.6%, -99.5% to 122.4%, and -108.6% to 170.0% in a small VOI of tumor with motion correction. Overall, the best reproducibility was obtained when measurements were obtained in the entire tumor (i.e., whole-tumor coverage) and when motion correction was used. CONCLUSION. Measurement reproducibility of perfusion parameters improved when measurements in the entire tumor (i.e., whole-tumor coverage) were obtained and computerized motion correction was used. The best reproducibility in parameter values was obtained with motion correction and whole-tumor coverage.
引用
收藏
页码:W603 / W609
页数:7
相关论文
共 20 条
  • [1] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
    BLAND, JM
    ALTMAN, DG
    [J]. LANCET, 1986, 1 (8476) : 307 - 310
  • [2] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
    Eisenhauer, E. A.
    Therasse, P.
    Bogaerts, J.
    Schwartz, L. H.
    Sargent, D.
    Ford, R.
    Dancey, J.
    Arbuck, S.
    Gwyther, S.
    Mooney, M.
    Rubinstein, L.
    Shankar, L.
    Dodd, L.
    Kaplan, R.
    Lacombe, D.
    Verweij, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) : 228 - 247
  • [3] Whole-Tumor Perfusion CT in Patients with Advanced Lung Adenocarcinoma Treated with Conventional and Antiangiogenetic Chemotherapy: Initial Experience
    Fraioli, Francesco
    Anzidei, Michele
    Zaccagna, Fulvio
    Mennini, Maria Luisa
    Serra, Goffredo
    Gori, Bruno
    Longo, Flavia
    Catalano, Carlo
    Passariello, Roberto
    [J]. RADIOLOGY, 2011, 259 (02) : 574 - 582
  • [4] Clinical translation of angiogenesis inhibitors
    Kerbel, R
    Folkman, J
    [J]. NATURE REVIEWS CANCER, 2002, 2 (10) : 727 - 739
  • [5] MEASUREMENT OF TISSUE PERFUSION BY DYNAMIC COMPUTED-TOMOGRAPHY
    MILES, KA
    [J]. BRITISH JOURNAL OF RADIOLOGY, 1991, 64 (761) : 409 - 412
  • [6] Standardized perfusion value: Universal CT contrast enhancement scale that correlates with FDG PET in lung nodules
    Miles, KA
    Griffiths, MR
    Fuentes, MA
    [J]. RADIOLOGY, 2001, 220 (02) : 548 - 553
  • [7] Reproducibility of CT Perfusion Parameters in Liver Tumors and Normal Liver
    Ng, Chaan S.
    Chandler, Adam G.
    Wei, Wei
    Herron, Delise H.
    Anderson, Ella F.
    Kurzrock, Razelle
    Chamsangavej, Chusilp
    [J]. RADIOLOGY, 2011, 260 (03) : 762 - 770
  • [8] Lung cancer perfusion at multi-detector row CT: Reproducibility of whole tumor quantitative measurements
    Ng, QS
    Goh, V
    Fichte, H
    Klotz, E
    Fernie, P
    Saunders, MI
    Hoskin, PJ
    Padhani, AR
    [J]. RADIOLOGY, 2006, 239 (02) : 547 - 553
  • [9] Quantitative assessment of lung cancer perfusion using MDCT: Does measurement reproducibility improve with greater tumor volume coverage?
    Ng, Quan Sing
    Goh, Vicky
    Klotz, Ernst
    Fichte, Heinz
    Saunders, Michele I.
    Hoskin, Peter J.
    Padhani, Anwar R.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2006, 187 (04) : 1079 - 1084
  • [10] Differentiation of Malignant and Benign Pulmonary Nodules with Quantitative First-Pass 320-Detector Row Perfusion CT versus FDG PET/CT
    Ohno, Yoshiharu
    Koyama, Hisanobu
    Matsumoto, Keiko
    Onishi, Yumiko
    Takenaka, Daisuke
    Fujisawa, Yasuko
    Yoshikawa, Takeshi
    Konishi, Minoru
    Maniwa, Yoshimasa
    Nishimura, Yoshihiro
    Ito, Tomoo
    Sugimura, Kazuro
    [J]. RADIOLOGY, 2011, 258 (02) : 599 - 609